Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma
about
The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small moleculeBlockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myelomaDivergent allosteric control of the IRE1α endoribonuclease using kinase inhibitorsIdentification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicingThe Role of Organelle Stresses in Diabetes Mellitus and Obesity: Implication for TreatmentCancer Microenvironment and Endoplasmic Reticulum Stress ResponseEndoplasmic Reticulum Stress in the Diabetic Kidney, the Good, the Bad and the UglyDrugging the unfolded protein response in acute leukemiasDangER: protein ovERload. Targeting protein degradation to treat myelomaXenobiotic perturbation of ER stress and the unfolded protein responseProtein homeostasis as a therapeutic target for diseases of protein conformationCrosstalk between the unfolded protein response and NF-κB-mediated inflammation in the progression of chronic kidney diseaseNovel therapeutic strategies for multiple myelomaTumor progression and the different faces of the PERK kinaseMolecular Pathways: Immunosuppressive Roles of IRE1α-XBP1 Signaling in Dendritic Cells of the Tumor MicroenvironmentX-box binding protein 1 (XBP1s) is a critical determinant of Pseudomonas aeruginosa homoserine lactone-mediated apoptosisTumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in CancerThe unfolded protein response in immunity and inflammationThe unfolded protein response: from stress pathway to homeostatic regulationMolecular mechanisms of human IRE1 activation through dimerization and ligand bindingExpression of inositol-requiring enzyme 1β is downregulated in colorectal cancerSynthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity.Thioredoxin-interacting protein links endoplasmic reticulum stress to inflammatory brain injury and apoptosis after subarachnoid haemorrhage.Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia.Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease.ER stress, autophagy, and RNA viruses.Endoplasmic reticulum stress and cancer.Dinaciclib (SCH727965) inhibits the unfolded protein response through a CDK1- and 5-dependent mechanismER stress activates NF-κB by integrating functions of basal IKK activity, IRE1 and PERK.A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patientsAllosteric inhibition of the IRE1α RNase preserves cell viability and function during endoplasmic reticulum stress.Discovery of Sulfonamidebenzamides as Selective Apoptotic CHOP Pathway Activators of the Unfolded Protein Response.Identification of small molecules that protect pancreatic β cells against endoplasmic reticulum stress-induced cell death.Identification and validation of novel PERK inhibitors.GCN5 inhibits XBP-1S-mediated transcription by antagonizing PCAF actionProteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy.The unfolded protein response is shaped by the NMD pathwayAn unexpected alliance between stress responses to drive oncogenesis.Cleavage of BLOC1S1 mRNA by IRE1 Is Sequence Specific, Temporally Separate from XBP1 Splicing, and Dispensable for Cell Viability under Acute Endoplasmic Reticulum StressAssay strategies for identification of therapeutic leads that target protein trafficking
P2860
Q24596804-AB824C52-D2EB-445C-8CB0-5B3643C0ED04Q24598483-876751FA-4A03-401F-B883-EDCD43A46CD7Q24606387-ED4603AF-A0B0-4629-BD43-31A97AB4A089Q24627782-036B4582-F966-4DF6-8DCB-53D79F28955BQ26776377-2E3C93A4-E697-4AEE-BA0D-1E5AD1F6B14BQ26778533-D2FDE259-8391-4B9D-B3DD-4DE6698B1D0AQ26799567-83F13E13-684D-45DB-A841-AEC3C602CEB6Q26801114-57880190-D438-4544-8504-8E2EF91184ADQ26825417-4ACC9786-7720-4B1B-89D0-0C5DFB2A8A8FQ26998690-E017D6DF-4F44-4ED6-93B2-F4B12848F14FQ27003283-35C4D52C-066F-46EE-BC3C-3FD7AA313FBBQ28080433-D4632DFB-1A02-487A-9544-C61679C38465Q28081590-09F2526C-C3F8-4A02-AB75-C29DF0D68775Q28087036-92C55B5B-727A-4DCB-8A8C-39215577F8D9Q28393599-48E7166E-2212-4CE9-A4BD-368885E3D258Q28535497-C6CED4DD-1BAC-4779-A28E-90DE444B143CQ29248711-CEFCE301-901B-439F-B59E-68DEDC1A093EQ29248713-49A8DA39-F643-4CA5-B0F8-D197AAA00934Q29547396-BC1DA246-4271-48B4-9EFD-867156161324Q30404387-967A845A-E1F7-4DD1-8B4C-8223FD85936BQ33598297-3B8E4A3B-7450-4940-AB49-B60BBB3B5543Q33654550-073C6449-0EA8-43BD-B5F6-4BE056E0C506Q33660621-EDCBEE86-DDEB-4513-8434-31BC969F2D87Q33694514-EBBD73E1-21DD-43B3-814B-A7E492032ABDQ33828303-892D9FC1-AC8E-4294-82E1-DF2E50B06A1EQ34003896-571732A8-4632-46C6-AD05-83DE8E2A7217Q34376123-67B553A6-5FBC-46C3-B5F9-BCD94877CC99Q34393767-785DEC8A-BE1E-4B37-B45D-FBAC04AFFCFCQ34460275-472566BD-453A-44F4-8D15-76368EDAF302Q34543937-9B10D829-3753-442C-ABCC-E2117983BBF5Q34572339-7B8B517E-3A57-46BC-B195-1E5960A9C7C1Q34701285-921E160C-8096-4592-A45F-7929E4ACD4E4Q34756838-E4AE051E-06E3-4CED-866E-704134D1F281Q35152423-A3E96F3E-9CE9-48DC-A984-3AD52630B96CQ35238447-96C5FBB5-11D0-4F29-9C63-4E1D4C33327BQ35408665-3F16A821-C9F6-4916-B77E-C8FCAF0C08AEQ35595494-D03A729B-1D0D-4BB5-AA7C-E17DC7C67330Q35599727-AE27EA2B-5E2B-48EF-91F2-B2E4FA15E4BDQ35626096-909FDAFE-760B-44D7-8ADE-DA59D6E7D09EQ35661403-78751AFF-F494-47B2-A28C-B6D2EA95D5CE
P2860
Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of an Ire1alpha ...... against human multiple myeloma
@ast
Identification of an Ire1alpha ...... against human multiple myeloma
@en
Identification of an Ire1alpha ...... against human multiple myeloma
@nl
type
label
Identification of an Ire1alpha ...... against human multiple myeloma
@ast
Identification of an Ire1alpha ...... against human multiple myeloma
@en
Identification of an Ire1alpha ...... against human multiple myeloma
@nl
prefLabel
Identification of an Ire1alpha ...... against human multiple myeloma
@ast
Identification of an Ire1alpha ...... against human multiple myeloma
@en
Identification of an Ire1alpha ...... against human multiple myeloma
@nl
P2093
P2860
P3181
P1433
P1476
Identification of an Ire1alpha ...... against human multiple myeloma
@en
P2093
Albert C Koong
David E Solow-Cordero
Donna M Bouley
Fritz Offner
Heleen Van Melckebeke
Ioanna Papandreou
Michael Olson
Nicholas C Denko
P2860
P304
P3181
P356
10.1182/BLOOD-2010-08-303099
P407
P577
2011-01-27T00:00:00Z